Fy a/Fy b antigen polymorphism in human erythrocyte duffy antigen affects susceptibility to Plasmodium vivax malaria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 50, 2011, Pages 20113-20118

  King, Christopher L ^a,b   Adams, John H ^c   Xianli, Jia ^a   Grimberg, Brian T ^a   McHenry, Amy M ^c   Greenberg, Lior J ^a   Siddiqui, Asim ^a   Howes, Rosalind E ^d   Silva Nunes, Monica Da ^e   Ferreira, Marcelo U ^e   Zimmerman, Peter A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Duffy binding protein; Resistance

Indexed keywords

DUFFY BINDING PROTEIN; FY A ANTIGEN; FY B ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; DNA POLYMORPHISM; ERYTHROCYTE MEMBRANE; GENE FREQUENCY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; PHENOTYPE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ARYLSULFATASES; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; RISK FACTORS;

EID: 84055181338     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109621108     Document Type: Article

References (32)

1. Price RN, Douglas NM, Anstey NM (2009) New developments in Plasmodium vivax malaria: Severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 22: 430-435.
2. Guerra CA, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4:e774.
3. Baird JK (2007) Neglect of Plasmodium vivax malaria. Trends Parasitol 23:533-539.
4. Tatem AJ, et al. (2010) Ranking of elimination feasibility between malaria-endemic countries. Lancet 376:1579-1591.
5. Krotoski WA (1989) The hypnozoite and malarial relapse. Prog Clin Parasitol 1: 1-19.
6. Persson KE, et al. (2008) Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 118:342-351.
7. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302-304.
8. Ménard D, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107:5967-5971.
9. Murphy PM, et al. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176. (Pubitemid 30127598)
10. Arévalo-Herrera M, Chitnis C, Herrera S (2010) Current status of Plasmodium vivax vaccine. Hum Vaccin 6:124-132.
11. Chitnis CE, Miller LH (1994) Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180:497-506. (Pubitemid 24224126)
12. Adams JH, et al. (1992) A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89:7085-7089.
13. Grimberg BT, et al. (2007) Antibodies directed Plasmodium vivax Duffy binding protein region inhibit P. vivax invasion of human erythrocytes. PLoS Med 4:e337.
14. King CL, et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci USA 105:8363-8368. (Pubitemid 351904761)
15. Pogo AO, Chaudhuri A (2000) The Duffy protein: A malarial and chemokine receptor. Semin Hematol 37:122-129. (Pubitemid 30211151)
16. Horuk R, Wang ZX, Peiper SC, Hesselgesser J (1994) Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J Biol Chem 269:17730-17733. (Pubitemid 24218061)
17. Li J, Iwamoto S, Sugimoto N, Okuda H, Kajii E (1997) Dinucleotide repeat in the 3′flanking region provides a clue to the molecular evolution of the Duffy gene. Hum Genet 99:573-577. (Pubitemid 27192584)
18. Tournamille C, et al. (2004) Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics 55:682-694. (Pubitemid 38221668)
19. Cavasini CE, et al. (2007) Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 6:167.
20. Haynes JD, et al. (1988) Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J Exp Med 167: 1873-1881.
21. Choe H, et al. (2005) Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol Microbiol 55:1413-1422. (Pubitemid 40342069)
22. Wilkins PP, Moore KL, McEver RP, Cummings RD (1995) Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem 270:22677-22680.
23. da Silva-Nunes M, et al. (2008) Malaria on the Amazonian frontier: Transmission dynamics, risk factors, spatial distribution, and prospects for control. Am J Trop Med Hyg 79:624-635.
24. Howes RE, et al. (2011) The global distribution of the Duffy blood group. Nat Commun 2:266.
25. Müller I, et al. (2009) Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection. Malar J 8:158.
26. Carter R (2003) Speculations on the origins of Plasmodium vivax malaria. Trends Parasitol 19:214-219.
27. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK (1975) Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189:561-563.
28. Mason SJ, Miller LH, Shiroishi T, Dvorak JA, McGinniss MH (1977) The Duffy blood group determinants: Their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. Br J Haematol 36:327-335. (Pubitemid 8149931)
29. Barnwell JW, Nichols ME, Rubinstein P (1989) In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169: 1795-1802. (Pubitemid 19126834)
30. Wertheimer SP, Barnwell JW (1989) Plasmodium vivax interaction with the human Duffy blood group glycoprotein: Identification of a parasite receptor-like protein. Exp Parasitol 69:340-350. (Pubitemid 19269872)
31. Tran TM, et al. (2005) Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. Cytometry A 63:59-66. (Pubitemid 40194280)
32. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH (1996) The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 184:1531-1536. (Pubitemid 26354709)